119 related articles for article (PubMed ID: 27389935)
1. Bifunctional Ligands for Inhibition of Tight-Binding Protein-Protein Interactions.
Ivan T; Enkvist E; Viira B; Manoharan GB; Raidaru G; Pflug A; Alam KA; Zaccolo M; Engh RA; Uri A
Bioconjug Chem; 2016 Aug; 27(8):1900-10. PubMed ID: 27389935
[TBL] [Abstract][Full Text] [Related]
2. High-affinity bisubstrate probe for fluorescence anisotropy binding/displacement assays with protein kinases PKA and ROCK.
Vaasa A; Viil I; Enkvist E; Viht K; Raidaru G; Lavogina D; Uri A
Anal Biochem; 2009 Feb; 385(1):85-93. PubMed ID: 19017524
[TBL] [Abstract][Full Text] [Related]
3. Efficient photocaging of a tight-binding bisubstrate inhibitor of cAMP-dependent protein kinase.
Sõrmus T; Lavogina D; Enkvist E; Uri A; Viht K
Chem Commun (Camb); 2019 Sep; 55(74):11147-11150. PubMed ID: 31464306
[TBL] [Abstract][Full Text] [Related]
4. Competitive ligands facilitate dissociation of the complex of bifunctional inhibitor and protein kinase.
Ivan T; Enkvist E; Sinijarv H; Uri A
Biophys Chem; 2017 Sep; 228():17-24. PubMed ID: 28651101
[TBL] [Abstract][Full Text] [Related]
5. cAMP-dependent protein kinase from brown adipose tissue: temperature effects on kinetic properties and enzyme role in hibernating ground squirrels.
MacDonald JA; Storey KB
J Comp Physiol B; 1998 Oct; 168(7):513-25. PubMed ID: 9810716
[TBL] [Abstract][Full Text] [Related]
6. Structure-based design of isoquinoline-5-sulfonamide inhibitors of protein kinase B.
Collins I; Caldwell J; Fonseca T; Donald A; Bavetsias V; Hunter LJ; Garrett MD; Rowlands MG; Aherne GW; Davies TG; Berdini V; Woodhead SJ; Davis D; Seavers LC; Wyatt PG; Workman P; McDonald E
Bioorg Med Chem; 2006 Feb; 14(4):1255-73. PubMed ID: 16249095
[TBL] [Abstract][Full Text] [Related]
7. Probing cAMP-dependent protein kinase holoenzyme complexes I alpha and II beta by FT-IR and chemical protein footprinting.
Yu S; Mei FC; Lee JC; Cheng X
Biochemistry; 2004 Feb; 43(7):1908-20. PubMed ID: 14967031
[TBL] [Abstract][Full Text] [Related]
8. Rapid evolution of 6-phenylpurine inhibitors of protein kinase B through structure-based design.
Donald A; McHardy T; Rowlands MG; Hunter LJ; Davies TG; Berdini V; Boyle RG; Aherne GW; Garrett MD; Collins I
J Med Chem; 2007 May; 50(10):2289-92. PubMed ID: 17451235
[TBL] [Abstract][Full Text] [Related]
9. Allosteric Effect of Adenosine Triphosphate on Peptide Recognition by 3'5'-Cyclic Adenosine Monophosphate Dependent Protein Kinase Catalytic Subunits.
Kivi R; Solovjova K; Haljasorg T; Arukuusk P; Järv J
Protein J; 2016 Dec; 35(6):459-466. PubMed ID: 27848106
[TBL] [Abstract][Full Text] [Related]
10. Ca
Fusi F; Trezza A; Spiga O; Sgaragli G; Bova S
Biochem Pharmacol; 2017 Sep; 140():53-63. PubMed ID: 28583845
[TBL] [Abstract][Full Text] [Related]
11. The structure of dimeric ROCK I reveals the mechanism for ligand selectivity.
Jacobs M; Hayakawa K; Swenson L; Bellon S; Fleming M; Taslimi P; Doran J
J Biol Chem; 2006 Jan; 281(1):260-8. PubMed ID: 16249185
[TBL] [Abstract][Full Text] [Related]
12. Discovery of spirocyclic sulfonamides as potent Akt inhibitors with exquisite selectivity against PKA.
Xu R; Banka A; Blake JF; Mitchell IS; Wallace EM; Bencsik JR; Kallan NC; Spencer KL; Gloor SL; Martinson M; Risom T; Gross SD; Morales TH; Wu WI; Vigers GP; Brandhuber BJ; Skelton NJ
Bioorg Med Chem Lett; 2011 Apr; 21(8):2335-40. PubMed ID: 21420856
[TBL] [Abstract][Full Text] [Related]
13. Effect of the structure of adenosine mimic of bisubstrate-analog inhibitors on their activity towards basophilic protein kinases.
Enkvist E; Kriisa M; Roben M; Kadak G; Raidaru G; Uri A
Bioorg Med Chem Lett; 2009 Nov; 19(21):6098-101. PubMed ID: 19800227
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase A inhibitor, H89, enhances survival and clonogenicity of dissociated human embryonic stem cells through Rho-associated coiled-coil containing protein kinase (ROCK) inhibition.
Zhang L; Xu Y; Xu J; Wei Y; Xu X
Hum Reprod; 2016 Apr; 31(4):832-43. PubMed ID: 26848187
[TBL] [Abstract][Full Text] [Related]
15. A structural comparison of inhibitor binding to PKB, PKA and PKA-PKB chimera.
Davies TG; Verdonk ML; Graham B; Saalau-Bethell S; Hamlett CC; McHardy T; Collins I; Garrett MD; Workman P; Woodhead SJ; Jhoti H; Barford D
J Mol Biol; 2007 Mar; 367(3):882-94. PubMed ID: 17275837
[TBL] [Abstract][Full Text] [Related]
16. Small-molecule FRET probes for protein kinase activity monitoring in living cells.
Vaasa A; Lust M; Terrin A; Uri A; Zaccolo M
Biochem Biophys Res Commun; 2010 Jul; 397(4):750-5. PubMed ID: 20541535
[TBL] [Abstract][Full Text] [Related]
17. Staurosporine tethered peptide ligands that target cAMP-dependent protein kinase (PKA): optimization and selectivity profiling.
Shomin CD; Meyer SC; Ghosh I
Bioorg Med Chem; 2009 Sep; 17(17):6196-202. PubMed ID: 19674907
[TBL] [Abstract][Full Text] [Related]
18. Structural insights into AGC kinase inhibition.
Breitenlechner C; Gassel M; Engh R; Bossemeyer D
Oncol Res; 2004; 14(6):267-78. PubMed ID: 15206489
[TBL] [Abstract][Full Text] [Related]
19. Staurosporine-induced conformational changes of cAMP-dependent protein kinase catalytic subunit explain inhibitory potential.
Prade L; Engh RA; Girod A; Kinzel V; Huber R; Bossemeyer D
Structure; 1997 Dec; 5(12):1627-37. PubMed ID: 9438863
[TBL] [Abstract][Full Text] [Related]
20. Structural analysis of protein kinase A mutants with Rho-kinase inhibitor specificity.
Bonn S; Herrero S; Breitenlechner CB; Erlbruch A; Lehmann W; Engh RA; Gassel M; Bossemeyer D
J Biol Chem; 2006 Aug; 281(34):24818-30. PubMed ID: 16699172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
